Excision margin of T3 basal cell carcinoma in maxillofacial area: A retrospective cohort study of Asians.

Surui ShengShuqun QiJian PanXingjun Qin

Published in: Oral diseases (2020)

This multicenter cohort study validated that T3 basal cell carcinoma Asian patients of maxillofacial area treated with excision margin of 6-9 mm had a substantial benefit of disease-free survival rate and skin conservation.

Keyphrases

basal cell carcinoma
free survival
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
clinical trial
wound healing
patient reported outcomes